4. Please articulate the risks that could inhibit success of the proposed project and the strategies your organization will use to mitigate the risks. (Please describe up to five key risks) Type of risk Risk description Mitigation strategy Strategic risks e.g. Changing market assumption affecting relevance of identified (What key assumptions could market problem or solution change and put at stake the relevance of the proposed project e.g. Duplication of intervention with to Unitaid?) other stakeholder Implementation risks e.g. Delays or shortage of supply for procurement (What key assumptions related to the project delivery and/or external e.g. Delays due to technical failure environment change and put at stake the successful e.g. Political instability implementation of the project?) Sustainability e.g. Non-identification of transition partner (What key assumptions related to the sustainability of the proposed e.g. Lack of funding for scale up approach change and put at stake the transition & scale-up?) e.g. weak evidence (e.g., clinical, operational, cost effectiveness) to justify the roll-out and use of a health product or approach.
4. Please articulate the risks that could inhibit success of the proposed project and the strategies your organization will use to mitigate the risks. (Please describe up to five key risks) Type of risk Risk description Mitigation strategy Strategic risks (What key assumptions could change and put at stake the relevance of the proposed project to Unitaid?) e.g. Changing market assumption affecting relevance of identified market problem or solution e.g. Duplication of intervention with other stakeholder Implementation risks (What key assumptions related to the project delivery and/or external environment change and put at stake the successful implementation of the project?) e.g. Delays or shortage of supply for procurement e.g. Delays due to technical failure e.g. Political instability Sustainability (What key assumptions related to the sustainability of the proposed approach change and put at stake the transition & scale-up?) e.g. Non-identification of transition partner e.g. Lack of funding for scale up e.g. weak evidence (e.g., clinical, operational, cost effectiveness) to justify the roll-out and use of a health product or approach.
Unitaid-Grant-Proposal-Form_17042018.docx